The FDA has resolved the shortage designations for semaglutide and tirzepatide and has proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list, stating it did not identify a clinical need for large-scale compounding of these substances
It also suppresses the release of glucagon , a hormone that raises blood glucose, and slows gastric emptying the rate at which food leaves the stomach and enters the small intestine
Moreover, SM-PNPs ameliorated HFD-induced alterations in fasting glucose and insulin levels and improved HOMA-IR indices, thereby restoring glucose homeostasis
Yi Z, Zhang M, Ma Z, Tuo B, Liu A, Deng Z, et al
He added that the recognition of GLP-1 biology as the Science Magazine 2023 breakthrough of the year "highlights the expanding clinical impact of GLP-1, and the tremendous potential for basic scientific discovery to continuously improve human health." Source: Journal reference: Wong, C